Jump to content
RemedySpot.com

Re: effect of mold on breast cancer patient

Rate this topic


Guest guest

Recommended Posts

I'm sure you'll get much better answers from others, but I can give you an EASY

answer -

Mold and mycotoxins are KNOWN to be hazardous to those who are

immunocompromised, and a cancer survivor would nearly certainly meet that test.

(The rest of us are still fighting to prove that they cause immunosuppression as

well, but that's another story).

If you do a search on 'mold' and 'immunocompromised' you should be able to

come up with enough information to take it to Legal Aid and have someone write a

letter to your human resources saying it could jeopardize her health. Better

yet, do the search in PubMed - there should be plenty of medical journal

articles on this subject. This should be something that would get her

'protection' (such as it is under this Administration which has been working to

dismantle these protections) under the Americans with Disabilities Act.

Best of luck - keep us posted.

~Haley

toxsickniagara <toxsickniagara@...> wrote:

One of my coworkers was recently diagnosed with breast cancer. Her

office is being reassigned to the basement of our building.

Stachybotrys and Aspergillus were removed in 2004 and 2005, and we are

not quite sure that all the mold was removed. We continue to have

problems with plumbing leaks, water intrusion, groundwater flooding,

sewer backups, and uncontrolled humidity. She is concerned that after

her breast surgery and during her radiation treatments that the

conditions in her office area may harm her health. Does anyone have a

link to any papers written on the effect of toxic mold on breast

cancer patients?

Link to comment
Share on other sites

May in his book " My house is killing me " that one should not

live or work in a basement for health reasons, in Chapter 9 on Finished

Basements.

>

> One of my coworkers was recently diagnosed with breast cancer. Her

> office is being reassigned to the basement of our building.

> Stachybotrys and Aspergillus were removed in 2004 and 2005,

Link to comment
Share on other sites

Thank you Barb - that reminded me that I have a book by May -

" My Office is Killing Me. " There is some info there about Aflotoxins

from Aspergillus mold, and about moisture and molds in basements. I

had forgotten about that. Thanks for the reminder.

>

> May in his book " My house is killing me " that one should not

> live or work in a basement for health reasons, in Chapter 9 on

Finished

> Basements.

>

>

Link to comment
Share on other sites

Okay, you should contact the autors of these studies for more info. I

am just copying and pasting here..

But, as I read this, many studies have shown that certain environments

that contain lots of bacteria - like basements that have seen

FLOODING, have BACTTERIAL ENDOTOXINS that strongly potentiate mold

effects. Also mold emits MVOCs while it is growing, complex volatile

chemicals.. They do other things.. So these situations are more

accurately described as MOLD + BACTERIA + MVOC situations, not mold

alone. The situation you described sounds like one of them. They are

the most dangerous. Sounds like they are trying to send her a message

that she might be better off elsewhere??? Huh? She should contact a

lawyer.

Mold toxins are potentiated very strongly by bacterial endotoxins,

such as are found in places that are damp and have seen sewer

intrusion or dead animals, etc. (like moldy basements) That makes the

cytoxic and inflammatory effects of the mold many more times stronger.

Stachybotrys often does not show up on tests. See the last abstract

for why. Were all the wall cavities cleaned out? Does it still smell

damp? What is the relative humidity down there, does it go above 50%

ever? (like at night)

Also, spore tests are notoriously GOOD at NOT SHOWING STACHYBOTRYS. In

fact, they rarely show it even when its really bad.

Thats why spore tests should not be used in post remediation clearance.

Toxicol Sci. 2007 Aug;98(2):526-41. Epub 2007 May 4.Click here to read Links

Neurotoxicity and inflammation in the nasal airways of mice

exposed to the macrocyclic trichothecene mycotoxin roridin a: kinetics

and potentiation by bacterial lipopolysaccharide coexposure.

Islam Z, Amuzie CJ, Harkema JR, Pestka JJ.

Department of Food Science and Human Nutrition, Michigan State

University, East Lansing, Michigan 48824, USA.

Macrocyclic trichothecene mycotoxins produced by indoor air molds

potentially contribute to symptoms associated with damp building

illnesses. The purpose of this investigation was to determine (1) the

kinetics of nasal inflammation and neurotoxicity after a single

intranasal instillation of roridin A (RA), a representative

macrocyclic trichothecene; and (2) the capacity of lipopolysaccharide

(LPS) to modulate RA's effects. C57Bl/6 female mice were intranasally

instilled once with 50 mul of RA (500 mug/kg body weight [bw]) in

saline or saline only and then nose and brain tissues were collected

over 72 h and processed for histopathologic and messenger RNA (mRNA)

analysis. RA-induced apoptosis specifically in olfactory sensory

neurons (OSNs) after 24 h postinstillation (PI) causing marked atrophy

of olfactory epithelium (OE) that was maximal at 72 h PI.

Concurrently, there was marked bilateral atrophy of olfactory nerve

layer of the olfactory bulbs (OBs) of the brain. In the ethmoid

turbinates, upregulated messenger RNA (mRNA) expression of the

proapoptotic gene FAS and the proinflammatory cytokines tumor necrosis

factor-alpha, interleukin (IL)-6, IL-1, and macrophage inhibitory

protein-2 was observed from 6 to 24 h PI, whereas expression of

several other proapoptotic genes (PKR, p53, Bax, and caspase-activated

DNAse) was detectable only at 24 h PI. Simultaneous exposure to LPS

(500 ng/kg bw) and a lower dose of RA (250 mug/kg bw) magnified

RA-induced proinflammatory gene expression, apoptosis, and

inflammation in the nasal tract. Taken together, the results suggest

that RA markedly induced FAS and proinflammatory cytokine expression

prior to evoking OSN apoptosis and OE atrophy and that RA's effects

were augmented by LPS.

PMID: 17483119 [PubMed - indexed for MEDLINE]

Deoxynivalenol and satratoxin G potentiate proinflammatory cytokine

and macrophage inhibitory protein 2 induction by Listeria and

Salmonella in the macrophage.

Mbandi E, Pestka JJ.

Department of Food Science and Human Nutrition and Center for

Integrative Toxicology, Michigan State University, East Lansing,

Michigan 48824, USA.

Health risks from microbial pathogens and toxins encountered in food

and the environment continue to be of worldwide concern. The purpose

of this research was to test the hypothesis that trichothecene

mycotoxins amplify inflammatory responses to foodborne bacterial

pathogens. We assessed the capacity of deoxynivalenol (DON) and

satratoxin G (SG) to potentiate chemokine and proinflammatory cytokine

production in RAW 264.7 murine macrophages induced by Listeria

monocytogenes and Salmonella Typhimurium. When macrophage cultures

were incubated with killed irradiated suspensions of the pathogens for

24 h, the minimum Listeria concentrations for induction of macrophage

inhibitory protein 2 (MIP-2), interleukin-1beta (IL-beta), IL-6, and

tumor necrosis factor alpha (TNF-alpha) were 0.01, 0.01, 1.0, and 1.0

microg/ml (P < 0.05) and the minimum Salmonella concentrations were

0.01, 0.01, 0.1, and 0.1 microg/ml, respectively (P < 0.05). Induction

of all four mediators by both pathogens was potentiated by DON (at 100

and 250 ng/ml); observed responses were significantly higher than

predicted additive responses (P < 0.05). SG (at 2 and 5 ng/ml) also

significantly amplified induction of IL-1beta and TNF-alpha (P < 0.05)

by both Listeria and Salmonella. These results indicate that DON

encountered in Fusarium-contaminated food and SG from

Stachybotrys-contaminated indoor environments could magnify innate

inflammatory responses to foodborne bacterial pathogens.

PMID: 16786854 [PubMed - indexed for MEDLINE]

Toxicol Sci. 2006 Aug;92(2):445-55. Epub 2006 May 9.Click here to read Links

Toll-like receptor priming sensitizes macrophages to

proinflammatory cytokine gene induction by deoxynivalenol and other

toxicants.

Pestka J, Zhou HR.

Department of Food Science and Human Nutrition, and Center for

Integrative Toxicology, Michigan State University, East Lansing,

48824, USA. pestka@...

Activation of the innate immune system might predispose a host to

toxicant-induced inflammation. In vitro macrophage models were

employed to investigate the effects of preexposure to Toll-like

receptor (TLR) agonists on induction of proinflammatory cytokine gene

expression by the trichothecene mycotoxin deoxynivalenol (DON) and

other toxicants. Priming of the murine RAW 264.7 macrophage line or

peritoneal murine macrophages with the TLR4 agonist lipopolysaccharide

(LPS) at 100 ng/ml for 4, 8, and 16 h significantly increased

DON-induced IL-1beta, IL-6, and TNF-alpha mRNA expression as compared

to LPS or DON alone. The minimum LPS concentration for sensitization

of both cell types was 1 ng/ml. LPS priming also potentiated IL-1beta

mRNA induction by DON in human whole-blood cultures, suggesting the

relevance of the murine findings. As observed for LPS, preexposure to

TLR agonists including zymosan (TLR2), poly (I:C) (TLR3), flagellin

(TLR5), R848 (TLR7/8), and ODN1826 (TLR9) sensitized RAW 267.4 cells

to DON-induced proinflammatory gene expression. Amplified

proinflammatory mRNA expression was similarly demonstrated in

LPS-sensitized RAW 264.7 cells exposed to the microbial toxins

satratoxin G, Shiga toxin, and zearalenone as well as the

anthropogenic toxicants nickel chloride, triphenyltin,

2,4-dinitrochlorobenzene, and 2,3,7,8-tetrachlorodibenzodioxin. The

results suggest that prior TLR activation might render macrophages

highly sensitive to subsequent induction of proinflammatory gene

expression by xenobiotics with diverse mechanisms of action.

PMID: 16687389 [PubMed - indexed for MEDLINE]

Toxicol In Vitro. 2006 Sep;20(6):899-909. Epub 2006 Mar 6.Click here

to read Links

In vitro effects of trichothecenes on human dendritic cells.

Hymery N, Sibiril Y, Parent-Massin D.

Laboratoire de Toxicologie Alimentaire, EA 3880 Université de

Bretagne Occidentale, Technopôle Brest-Iroise 29280 Plouzané, France.

The aim of this work was to study the in vitro effects of

trichothecenes on human dendritic cells. Trichothecenes are mycotoxins

produced by fungi such as Fusarium, Myrothecium, and Stachybotrys. Two

aspects have been explored in this work: the cytotoxicity of

trichothecenes on immature dendritic cells to determine IC 50

(inhibition concentration), and the effects of trichothecenes on

dendritic cell maturation process. Two mycotoxins (T-2 and DON) known

to be immunotoxic have been tested on a model of monocyte-derived

dendritic cells culture. Cytotoxic effects of T-2 toxin and DON on

immature dendritic cells showed that DON is less potent than T-2

toxin. The exposure to trichothecenes during dendritic cell maturation

upon addition of LPS or TNF-alpha markedly inhibited the up-regulation

of maturation markers such as CD-86, HLA-DR and CCR7. Features of LPS

or TNF-alpha -mediated maturation of dendritic cells, such as IL-10

and IL-12 secretions and endocytosis, were also impaired in response

to trichothecenes treatment. These results suggest trichothecenes have

adverse effects on dendritic cells and dendritic cell maturation

process.

PMID: 16517116 [PubMed - indexed for MEDLINE]

Toxicol Sci. 2007 Aug;98(2):526-41. Epub 2007 May 4.Click here to read Links

Neurotoxicity and inflammation in the nasal airways of mice

exposed to the macrocyclic trichothecene mycotoxin roridin a: kinetics

and potentiation by bacterial lipopolysaccharide coexposure.

Islam Z, Amuzie CJ, Harkema JR, Pestka JJ.

Department of Food Science and Human Nutrition, Michigan State

University, East Lansing, Michigan 48824, USA.

Macrocyclic trichothecene mycotoxins produced by indoor air molds

potentially contribute to symptoms associated with damp building

illnesses. The purpose of this investigation was to determine (1) the

kinetics of nasal inflammation and neurotoxicity after a single

intranasal instillation of roridin A (RA), a representative

macrocyclic trichothecene; and (2) the capacity of lipopolysaccharide

(LPS) to modulate RA's effects. C57Bl/6 female mice were intranasally

instilled once with 50 mul of RA (500 mug/kg body weight [bw]) in

saline or saline only and then nose and brain tissues were collected

over 72 h and processed for histopathologic and messenger RNA (mRNA)

analysis. RA-induced apoptosis specifically in olfactory sensory

neurons (OSNs) after 24 h postinstillation (PI) causing marked atrophy

of olfactory epithelium (OE) that was maximal at 72 h PI.

Concurrently, there was marked bilateral atrophy of olfactory nerve

layer of the olfactory bulbs (OBs) of the brain. In the ethmoid

turbinates, upregulated messenger RNA (mRNA) expression of the

proapoptotic gene FAS and the proinflammatory cytokines tumor necrosis

factor-alpha, interleukin (IL)-6, IL-1, and macrophage inhibitory

protein-2 was observed from 6 to 24 h PI, whereas expression of

several other proapoptotic genes (PKR, p53, Bax, and caspase-activated

DNAse) was detectable only at 24 h PI. Simultaneous exposure to LPS

(500 ng/kg bw) and a lower dose of RA (250 mug/kg bw) magnified

RA-induced proinflammatory gene expression, apoptosis, and

inflammation in the nasal tract. Taken together, the results suggest

that RA markedly induced FAS and proinflammatory cytokine expression

prior to evoking OSN apoptosis and OE atrophy and that RA's effects

were augmented by LPS.

PMID: 17483119 [PubMed - indexed for MEDLINE]

Link to comment
Share on other sites

LOTS of women from my former workplace have been diagnosed with breast

cancer....but its a " safe " building, according to the CEO. We all know

what B.S. that is, right?!

:>(

>

> One of my coworkers was recently diagnosed with breast cancer. Her

> office is being reassigned to the basement of our building.

> Stachybotrys and Aspergillus were removed in 2004 and 2005, and we

are

> not quite sure that all the mold was removed. We continue to have

> problems with plumbing leaks, water intrusion, groundwater flooding,

> sewer backups, and uncontrolled humidity. She is concerned that

after

> her breast surgery and during her radiation treatments that the

> conditions in her office area may harm her health. Does anyone have

a

> link to any papers written on the effect of toxic mold on breast

> cancer patients?

>

Link to comment
Share on other sites

, its really good to see you back!!!

I hope that you get better!

Just curious, how do they " know " that its supposedly safe?

Have they ever explained their line of reasoning in some place

where its been put on paper?

On Jan 21, 2008 8:04 PM, tori_annquilts <tori_annquilts@...> wrote:

>

>

> LOTS of women from my former workplace have been diagnosed with breast

> cancer....but its a " safe " building, according to the CEO. We all know

> what B.S. that is, right?!

> :>(

>

Link to comment
Share on other sites

This scares the s@$t out of me. I'm BRCA2 gene mutation positive and

I've been exposed to mold. Christ I already have an 82% chance of

getting breast cancer. Now what are my odds?

Sharon Hanson

>

> LOTS of women from my former workplace have been diagnosed with

breast

> cancer....but its a " safe " building, according to the CEO. We all

know

> what B.S. that is, right?!

> :>(

> >

Link to comment
Share on other sites

There were many young women with breast cancer, menstrual problems,

thyroid cancer (1 case), miscarriages, and other health problems

working at United HealthCare when I worked there too. I tried to get a

chart of cancer cases in my area from the ACS, but they wouldn't give

me any info. That was the last time I donated or gave my time to them.

Barth

---

t>

t> LOTS of women from my former workplace have been diagnosed with breast

t> cancer....but its a " safe " building, according to the CEO. We all know

t> what B.S. that is, right?!

:>>(

>>

>> One of my coworkers was recently diagnosed with breast cancer. Her

>> office is being reassigned to the basement of our building.

>> Stachybotrys and Aspergillus were removed in 2004 and 2005, and we

t> are

>> not quite sure that all the mold was removed. We continue to have

>> problems with plumbing leaks, water intrusion, groundwater flooding,

>> sewer backups, and uncontrolled humidity. She is concerned that

t> after

>> her breast surgery and during her radiation treatments that the

>> conditions in her office area may harm her health. Does anyone have

t> a

>> link to any papers written on the effect of toxic mold on breast

>> cancer patients?

>>

Link to comment
Share on other sites

,

This does not surprise me as the ACS has been privatized and these

organizations want to take control of the agenda on cancer research.

That way they can make more money by coming up with treatments that

don't work and cost a lot of money. This is my opinion.

Sharon

On February 27, 2002, Senator Dianne Feinstein (D-CA) introduced The

National Cancer Act of 2002 (S.1976). Co-sponsored by 30 bipartisan

Senators, including Majority Leader Tom Daschle (D-SD) and

Clinton (D-NY), the Bill is a radically different version of the 1971

Act that launched the National Cancer Program. The Bill adds $1.4

billion to the $4.6 billion 2003 budget authorized by President Bush,

extra funds coming from the new Federal cigarette tax increase, and a

further 50% annual increase to 2007, reaching a grand total of $14

billion. Feinstein said her goal is to " form our new battle plan to

fight cancer. " The legislation was referred to the Committee on

Health, Education, Labor, and Pensions, then chaired by Senator Judd

Gregg (R-NH). In April 2002, a similar bill, with 11 co-sponsors, was

submitted to the House of Representatives.

These Bills establish a national network of 20 " translation " centers

to combine basic and clinical research, and to commercialize

promising findings. They also mandate insurance coverage for cancer

screening, smoking cessation, genetic testing, and quality care

standards, while making no reference to prevention.

Regrettably, this well-intentioned Bill unwittingly surrenders the

National Cancer Program to special interests. The legislation has

been strongly criticized by survivor coalitions, headed by the Cancer

Leadership Council, and also the American Society for Clinical

Oncology (ASCO). Of major concern, the Bill displaces control of

cancer policy from the public to the private sector, the federal NCI

to the " nonprofit " ACS, and thus creates confusing duplication and

overlapping responsibility.

American Cancer Society Seeks Control of U. S. Cancer Policy

As disturbing as the Bill is its background. Meeting behind closed

doors in September 1998, the ACS created, funded and promoted the

National Dialogue on Cancer (NDC). This was co-chaired by former

President Bush and Barbara Bush, with Senator Feinstein as

vice-chairman, and former Governors Tom Ridge of Pennsylvania and

Tommy of Wisconsin as " Collaborating Partners " (37).

Included also were some 100 representatives of survivor groups and

the cancer drug industry. The NDC leadership, including ACS President-

Elect Dr. Von Eschenbach, without informing its NDC

participants, then unilaterally spun off its own Legislative

Committee, co-chaired by Dr. Seffrin, CEO of the ACS, and Dr.

DeVita, NCI director from 1980 to 1988, to advise Congress on

the proposed new Act. DeVita's track record as NCI Director was

characterized by hostility to cancer prevention, and attempts to

mislead Congress to the contrary (12).

http://www.preventcancer.com/losing/nci/nci_privatization.htm

--- In , Patilla DaHun <glypella@...>

wrote:

>

> There were many young women with breast cancer, menstrual problems,

> thyroid cancer (1 case), miscarriages, and other health problems

> working at United HealthCare when I worked there too. I tried to

get a

> chart of cancer cases in my area from the ACS, but they wouldn't

give

> me any info. That was the last time I donated or gave my time to

them.

>

> Barth

>

>

>

Link to comment
Share on other sites

Good opinion, Sharon!

Barth

---

S> ,

S> This does not surprise me as the ACS has been privatized and these

S> organizations want to take control of the agenda on cancer research.

S> That way they can make more money by coming up with treatments that

S> don't work and cost a lot of money. This is my opinion.

S> Sharon

S> On February 27, 2002, Senator Dianne Feinstein (D-CA) introduced The

S> National Cancer Act of 2002 (S.1976). Co-sponsored by 30 bipartisan

S> Senators, including Majority Leader Tom Daschle (D-SD) and

S> Clinton (D-NY), the Bill is a radically different version of the 1971

S> Act that launched the National Cancer Program. The Bill adds $1.4

S> billion to the $4.6 billion 2003 budget authorized by President Bush,

S> extra funds coming from the new Federal cigarette tax increase, and a

S> further 50% annual increase to 2007, reaching a grand total of $14

S> billion. Feinstein said her goal is to " form our new battle plan to

S> fight cancer. " The legislation was referred to the Committee on

S> Health, Education, Labor, and Pensions, then chaired by Senator Judd

S> Gregg (R-NH). In April 2002, a similar bill, with 11 co-sponsors, was

S> submitted to the House of Representatives.

S> These Bills establish a national network of 20 " translation " centers

S> to combine basic and clinical research, and to commercialize

S> promising findings. They also mandate insurance coverage for cancer

S> screening, smoking cessation, genetic testing, and quality care

S> standards, while making no reference to prevention.

S> Regrettably, this well-intentioned Bill unwittingly surrenders the

S> National Cancer Program to special interests. The legislation has

S> been strongly criticized by survivor coalitions, headed by the Cancer

S> Leadership Council, and also the American Society for Clinical

S> Oncology (ASCO). Of major concern, the Bill displaces control of

S> cancer policy from the public to the private sector, the federal NCI

S> to the " nonprofit " ACS, and thus creates confusing duplication and

S> overlapping responsibility.

S> American Cancer Society Seeks Control of U. S. Cancer Policy

S> As disturbing as the Bill is its background. Meeting behind closed

S> doors in September 1998, the ACS created, funded and promoted the

S> National Dialogue on Cancer (NDC). This was co-chaired by former

S> President Bush and Barbara Bush, with Senator Feinstein as

S> vice-chairman, and former Governors Tom Ridge of Pennsylvania and

S> Tommy of Wisconsin as " Collaborating Partners " (37).

S> Included also were some 100 representatives of survivor groups and

S> the cancer drug industry. The NDC leadership, including ACS President-

S> Elect Dr. Von Eschenbach, without informing its NDC

S> participants, then unilaterally spun off its own Legislative

S> Committee, co-chaired by Dr. Seffrin, CEO of the ACS, and Dr.

S> DeVita, NCI director from 1980 to 1988, to advise Congress on

S> the proposed new Act. DeVita's track record as NCI Director was

S> characterized by hostility to cancer prevention, and attempts to

S> mislead Congress to the contrary (12).

S> http://www.preventcancer.com/losing/nci/nci_privatization.htm

S>

>>

>> There were many young women with breast cancer, menstrual problems,

>> thyroid cancer (1 case), miscarriages, and other health problems

>> working at United HealthCare when I worked there too. I tried to

S> get a

>> chart of cancer cases in my area from the ACS, but they wouldn't

S> give

>> me any info. That was the last time I donated or gave my time to

S> them.

>>

>> Barth

>>

>>

>>

Link to comment
Share on other sites

--- In , " Does anyone have a

link to any papers written on the effect of toxic mold on breast

cancer patients?

, I don't have any info on that, but usually most cancer

patients go through treatments that affect their immune system (lower)

& IMO exposure to any fungus or bacteria to those patients would be

detrimental to their healing. I pray your lumps are just that (lumps)

& benign!

Hugs, Cheryl

Link to comment
Share on other sites

Just wanted to thank you all for the info on mold and breast cancer.

My coworker's move the basement offices where we've had mold growth is

postponed. Now all she can concentrate on her surgery and getting

herself better without worrying about working in a moldy basement.

Thanks for your help.

-- In , " Cheryl " <sunbum256@...> wrote:

>

> --- In , " Does anyone have a

> link to any papers written on the effect of toxic mold on breast

> cancer patients?

>

> , I don't have any info on that, but usually most cancer

> patients go through treatments that affect their immune system

(lower)

> & IMO exposure to any fungus or bacteria to those patients would be

> detrimental to their healing. I pray your lumps are just that

(lumps)

> & benign!

> Hugs, Cheryl

>

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...